re: Ann: Clinuvel commences US Phase III tria... They're not known to.
The FDA will usually provide pharmas with a calendar date for the decision. You'll get a panel review date and a final decision date. The panel review will usually give an idea of which way the final decision will go.
However, it can get a little tricky even with the FDA approval date at times as they can sometimes slip in a decision a couple weeks beforehand and stun investors with some bad news who were holding waiting closer to the appointed calendar date. That's why many investors clear the deck about 2 weeks before the FDA decision date.
But, the FDA is much better at clarity on a decision date than the European regulators are. Playing biotechs / pharma stocks isn't recommended for those with a pacemaker.
- Forums
- ASX - By Stock
- CUV
- Ann: Clinuvel commences US Phase III trial of SCE
Ann: Clinuvel commences US Phase III trial of SCE, page-7
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.12 |
Change
0.250(1.80%) |
Mkt cap ! $706.8M |
Open | High | Low | Value | Volume |
$13.90 | $14.17 | $13.90 | $675.2K | 48.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 293 | $14.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.12 | 261 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 293 | 14.010 |
2 | 1193 | 14.000 |
1 | 293 | 13.980 |
1 | 293 | 13.960 |
1 | 729 | 13.950 |
Price($) | Vol. | No. |
---|---|---|
14.120 | 261 | 1 |
14.140 | 293 | 1 |
14.160 | 293 | 1 |
14.180 | 293 | 1 |
14.250 | 500 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
CUV (ASX) Chart |